VLS — Vita Life Sciences Balance Sheet
0.000.00%
Last trade - 00:00
- AU$132.54m
- AU$108.23m
- AU$74.16m
- 99
- 71
- 89
- 97
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 10.5 | 14.5 | 15.9 | 15.7 | 24.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 7.76 | 6.94 | 7.12 | 8.98 | 11.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 25.8 | 29.2 | 35.1 | 41.2 | 48.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9.14 | 8.37 | 8.26 | 8.47 | 9.17 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 36.5 | 39.1 | 45.3 | 51.8 | 59.8 |
Accounts Payable | |||||
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12.1 | 13 | 14.5 | 14.9 | 16.2 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 13.9 | 14.4 | 14.5 | 15.2 | 16.4 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 22.6 | 24.7 | 30.8 | 36.6 | 43.4 |
Total Liabilities & Shareholders' Equity | 36.5 | 39.1 | 45.3 | 51.8 | 59.8 |
Total Common Shares Outstanding |